Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors

EMBO Journal

Volumn 18, Issue 5, 1999, Pages 1235-1244

  Zoli, Michele ^a   Picciotto, Marina R ^a,b   Ferrari, Rosaria ^c   Cocchi, Daniela ^c   Changeux, Jean Pierre ^a  

^a INSTITUT PASTEUR   (France)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

Ageing; Gliosis; Homologous recombination; Neurodegeneration; Nicotinic acetylcholine receptor

Indexed keywords

CORTISONE; NICOTINIC RECEPTOR;

AGING; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BIOCHEMISTRY; CHOLINERGIC SYSTEM; COGNITION; CORTICOSTERONE BLOOD LEVEL; HIPPOCAMPUS; HYPOTROPHY; LEARNING; MICROGLIA; MOUSE; NEOCORTEX; NERVE DEGENERATION; NEUROANATOMY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RECEPTOR AFFINITY;

EID: 0033104499     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.5.1235     Document Type: Article

References (64)

1. Abdulla, F.A., Calaminici, M.R., Stephenson, J.D. and Sinden, J.D. (1993) Chronic treatments with cholinoceptor drugs influence spatial learning in rats. Psychopharmacology (Berlin), 111, 508-511.
2. Aubert, I., Araujo, D.M., Cécyre, D., Robitaille, Y., Gauthier, S. and Quirion, R. (1992) Comparative alteration of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J. Neurochem., 58, 529-541.
3. Bancroft, J.D. and Stevens, A. (1982) Theory and Practice of Histological Techniques, Churchill Livingstone, Edinburgh, UK.
4. Bartus, R.T., Dean, R.L.III, Beer, B. and Lippa, A.S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-414.
5. Belluardo, N., Blum, M., Mudo, G., Andbjer, B. and Fuxe, K. (1998) Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat. Neuroscience, 83, 723-740.
6. Benfenati, F., Cimino, M., Agnati, L.F. and Fuxe, K. (1986) Quantitative autoradiography of central neurotransmitter receptors: methodological and statistical aspects with special reference to computer-assisted image analysis. Acta Physiol. Scand., 128, 129-146.
7. Borlongan, C.V., Shytle, R.D., Ross, S.D., Shimizu, T., Freeman, T.B., Cahill, D.W. and Sanberg, P.R. (1995) (-)-Nicotine protects against systemic kainic acid-induced excitotoxic effects. Exp. Neurol., 136, 261-265.
8. Breitner, J.C. (1996) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu. Rev. Med, 47, 401-411.
9. Brioni, J.D., O'Neill, A.B., Kim, D.J.B. and Decker, M.W. (1993) Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol., 238, 1-8.
10. Caggiula, A.R., Epstein, L.H., Antelman, S.M., Saylor, S.S., Perkins, K.A., Knopf, S. and Stiller, R. (1991) Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine. Pharmacol. Biochem. Behav., 40, 53-59.
11. Calhoun, M.E., Wiederhold, K.H., Abramowski, D., Phinney, A.L., Probst, A., Sturchlerpierrat, C., Staufenbiel, M., Sommer, B. and Jucker, M. (1998) Neuron loss in APP transgenic mice. Nature, 395, 755-756.
12. Chappell, J., McMahan, R., Chiba, A. and Gallagher, M. (1998) A reexamination of the role of basal forebrain cholinergic neurons in spatial working memory. Neuropharmacology, 37, 481-487.
13. 3H]-dopamine release. Br. J. Pharmacol., 117, 595-606.
14. Cocchi, D. (1992) Age-related alterations in gonadotropin, adreno-corticotropin and growth hormone secretion. Aging, 4, 103-113.
15. Coleman, P.D. and Flood, D.G. (1987) Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol. Aging, 8, 521-545.
16. Decker, M.W. (1987) The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res., 434, 423-138.
17. Decker, M.W., Curzon, P., Brioni, J.D. and Arneric, S.P. (1994) Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur. J. Pharmacol., 261, 217-222.
18. Elrod, K. and Buccafusco, J.J. (1991) Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats. J. Pharmacol. Exp. Ther., 258, 403-409.
19. Franklin, K.B.J. and Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
20. Gallagher, M. and Colombo, P.J. (1995) Ageing: the cholinergic hypothesis of cognitive decline. Curr. Opin. Neurobiol., 5, 161-168.
21. Gallagher, M. and Nicolle, M.M. (1993) Animal models of normal aging: relationship between cognitive decline and markers in hippocampal circuitry. Behav. Brain Res., 57, 155-162.
22. Gower, A.J. and Lamberty, Y. (1993) The aged mouse as a model of cognitive decline with special emphasis on studies in NMRI mice. Behav. Brain Res., 57, 163-173.
23. 3H]hemicholinium-3 as a quantitative marker. J. Neurochem., 60, 1191-1201.
24. Hardy, J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci., 20, 154-159.
25. Hill, J.A.,Jr, Zoli, M., Bourgeois, J.-P. and Changeux, J.-P. (1993) Immunocytochemical localization of a neuronal nicotinic receptor: the β2 subunit. J. Neurosci., 13, 1551-1568.
26. Jarvik, M.E. (1991) Beneficial effects of nicotine. Br. J. Addict., 86, 571-575.
27. Jucker, M., Walker, L.C., Kuo, H., Tian, M. and Ingram, D.K. (1994) Age-related fibrillar deposits in brains of C57BL/6 mice. A review of localization, staining characteristics and strain specificity. Mol. Neurobiol., 9, 125-133.
28. Kasa, P., Rakonczay, Z. and Gulya, K. (1997) The cholinergic system in Alzheimer's disease. Prog. Neurobiol., 52, 511-535.
29. Kihara, T., Shimohama, S., Urushitani, M., Sawada, H., Kimura, J., Kume, T., Maeda, T. and Akaike, A. (1998) Stimulation of α4-β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity. Brain Res., 792, 331-334.
30. Kohama, S.G., Goss, J.R., Finch, C.E. and McNeill, T.H. (1995) Increases of glial fibrillary acidic protein in the aging female mouse brain. Neurobiol. Aging, 16, 59-67.
31. Le Novère, N. and Changeux, J.-P. (1995) Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol, 40, 155-172.
32. Levin, E.D. (1992) Nicotinic systems and cognitive function. Psychopharmacology (Berlin), 108, 417-431.
33. Maggio, R., Riva, M., Vaglini, F., Fornai, F., Racagni, G. and Corsini, G.U. (1997) Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. J. Neural Transm., 104, 1113-1123.
34. Marin, P., Maus, M., Desagher, S., Glowinski, J. and Premont, J. (1994) Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity. Neuroreport, 5, 1977-1980.
35. Marin, P., Hamon, B., Glowinski, J. and Premont, J. (1997) Nicotine-induced inhibition of neuronal phospholipase A2. J. Pharmacol. Exp. Ther., 280, 1277-1283.
36. McEwen, B.S. and Sapolsky, R.M. (1995) Stress and cognitive function. Curr. Opin. Neurobiol., 5, 205-216.
37. McGurk, S.R., Levin, E.D. and Butcher, L.L. (1989) Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. Psychopharmacology (Berlin), 99, 371-373.
38. McGurk, S.R., Levin, E.D. and Butcher, L.L. (1991) Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists. Neuroscience, 44, 137-147.
39. McMillian, M.K., Thai, L., Hong, J.S., O'Callaghan, J.P. and Pennypacker, K.R. (1994) Brain injury in a dish: a model for reactive gliosis. Trends Neurosci., 17, 138-142.
40. Morris, R.G.M. (1989) Synaptic plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J. Neurosci., 9, 3040-3057.
41. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci. Lett., 72, 115-119.
42. Perry, V.H., Matyszak, M.K. and Fearn, S. (1993) Altered antigen expression of microglia in the aged rodent CNS. Glia, 7, 60-67.
43. Picciotto, M.R. et al. (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature, 374, 65-67.
44. Picciotto, M.R., Zoli, M., Rimondini, R., Léna, C., Marubio, L.M., Merlo Pich, E., Fuxe, K. and Changeux, J.-P. (1998) Acetylcholine receptors containing the β-2 subunit are involved in the reinforcing properties of nicotine. Nature, 391, 173-177.
45. Robbins, T.W., McAlonan, G., Muir, J.L. and Everitt, B.J. (1997) Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease. Behav. Brain Res., 83, 15-23.
46. Robertson, R.T. et al. (1998) Neonatal treatment with 192 IgG-saporin produces long-term forebrain cholinergic deficits and reduces dendritic branching and spine density of neocortical pyramidal neurons. Cerebral Cortex, 8, 142-155.
47. Role, L.W. and Berg, D.K. (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16, 1077-1085.
48. Rozovsky, I., Finch, C.E. and Morgan, T.E. (1998) Age-related activation of microglia and astrocytes - in vitro studies show persistent phenotypes of aging, increased proliferation and resistance to down-regulation. Neurobiol. Aging, 19, 97-103.
49. Sapolsky, R.M. (1996) Why stress is bad for your brain. Science, 273, 749-750.
50. Selkoe, D.J. (1994) Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol., 10, 373-403.
51. Semba, J., Miyoshi, R. and Kito, S. (1996) Nicotine protects against the dexamethasone potentiation of kainic acid-induced neurotoxicity in cultured hippocampal neurons. Brain Res., 735, 335-338.
52. Shimada, A., Hosokawa, M., Ohta, A., Akiguchi, I. and Takeda, T. (1994) Localization of atrophy-prone areas in the aging mouse brain: comparison between the brain atrophy model SAM-P/10 and the normal control SAM-R/1. Neuroscience, 59, 859-869.
53. Shimohama, S., Akaike, A. and Kimura, J. (1996) Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation. Ann. NY Acad. Sci., 777, 356-361.
54. 3H]GABA uptake in nucleus basalis lesioned rats. Brain Res., 624, 295-298.
55. Socci, D.J. and Arendash, G.W. (1996) Chronic nicotine treatment prevents neuronal loss in neocortex resulting from nucleus basalis lesions in young adult and aged rats. Mol. Chem. Neuropathol., 27, 285-305.
56. Socci, D.J., Sanberg, P.R. and Arendash, G.W. (1995) Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol. Aging, 16, 857-860.
57. Strittmatter, W.J. and Roses, A.D. (1996) Apolipoprotein E and Alzheimer's disease. Annu. Rev. Neurosci., 19, 53-77.
58. Summers, K.L. and Giacobini, E. (1995) Effects of local and repeated systemic administration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine and serotonin in rat cortex. Neurochem. Res., 20, 753-759.
59. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology, 38, 720-723.
60. Wilson, A.L., Langley, L.K., Monley, J., Bauer, T., Rottunda, S., McFalls, E., Kovera, C. and McCarten, J.R. (1995) Nicotine patches in Alzheimer's disease: pilot study on learning, memory and safety. Pharmacol. Biochem. Behav., 51, 509-514.
61. Zoli, M., Zini, I., Agnati, L.F., Guidolin, D., Ferraguti, F. and Fuxe, K. (1990) Aspects of neural plasticity in the central nervous system. I. Computer-assisted image analysis methods. Neurochem. Int.. 16, 383-418.
62. Zoli, M., Guidolin, D. and Agnati, L.F. (1992) Morphometric evaluation of populations of neuronal profiles (cell bodies, dendrites and nerve terminals) in the central nervous system. Microsc. Res. Tech., 21, 315-337.
63. Zoli, M., Grimaldi, R., Ferrari, R., Zini, I. and Agnati, L.F. (1997) Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats. Stroke, 28, 1049-1058.
64. Zoli, M., Léna, C., Picciotto, M.R. and Changeux, J.-P. (1998) Identification of four classes of brain nicotinic receptors using β2-mutant mice. J. Neurosci, 18, 4461-4472.